JP2016510747A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016510747A5 JP2016510747A5 JP2015561608A JP2015561608A JP2016510747A5 JP 2016510747 A5 JP2016510747 A5 JP 2016510747A5 JP 2015561608 A JP2015561608 A JP 2015561608A JP 2015561608 A JP2015561608 A JP 2015561608A JP 2016510747 A5 JP2016510747 A5 JP 2016510747A5
- Authority
- JP
- Japan
- Prior art keywords
- solid oral
- oral dosage
- dosage form
- mixture
- citric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361772927P | 2013-03-05 | 2013-03-05 | |
| US61/772,927 | 2013-03-05 | ||
| US201461925443P | 2014-01-09 | 2014-01-09 | |
| US61/925,443 | 2014-01-09 | ||
| PCT/US2014/020763 WO2014138241A1 (en) | 2013-03-05 | 2014-03-05 | Pharmaceuticals for oral delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016510747A JP2016510747A (ja) | 2016-04-11 |
| JP2016510747A5 true JP2016510747A5 (enExample) | 2017-04-06 |
| JP6375314B2 JP6375314B2 (ja) | 2018-08-15 |
Family
ID=50391422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015561608A Active JP6375314B2 (ja) | 2013-03-05 | 2014-03-05 | 固体経口投与剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US9457086B2 (enExample) |
| EP (1) | EP2964193B1 (enExample) |
| JP (1) | JP6375314B2 (enExample) |
| CN (1) | CN105101950B (enExample) |
| AU (3) | AU2014225822B2 (enExample) |
| CA (1) | CA2904327C (enExample) |
| DK (1) | DK2964193T3 (enExample) |
| ES (1) | ES2774962T3 (enExample) |
| IL (1) | IL240666A0 (enExample) |
| WO (1) | WO2014138241A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050282756A1 (en) | 2004-06-18 | 2005-12-22 | Mehta Nozer M | Oral delivery of peptide pharmaceutical compositions |
| US8377863B2 (en) | 2007-05-29 | 2013-02-19 | Unigene Laboratories Inc. | Peptide pharmaceutical for oral delivery |
| CN105101950B (zh) | 2013-03-05 | 2019-10-11 | 安特里斯生物制药公司 | 口服递送的药物 |
| JP6910950B2 (ja) * | 2015-01-12 | 2021-07-28 | エンテリス・バイオファーマ・インコーポレイテッドＥｎｔｅｒｉｓ Ｂｉｏｐｈａｒｍａ，Ｉｎｃ． | 固形経口剤形 |
| WO2021155042A1 (en) | 2020-01-28 | 2021-08-05 | Genentech, Inc. | Il15/il15r alpha heterodimeric fc-fusion proteins for the treatment of cancer |
| EP4536684A1 (en) | 2022-06-13 | 2025-04-16 | B.A.I. Laboratories, LLC | Interleukin-13 binding cyclic oligopeptides and methods of use thereof |
| WO2025240494A1 (en) | 2024-05-13 | 2025-11-20 | Lumen Bioscience, Inc. | Leptin compositions and methods of making and using the same to support weight loss and/or maintenance |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2956926A (en) * | 1958-09-23 | 1960-10-18 | American Cyanamid Co | Coated citric acid particles |
| NZ196348A (en) * | 1980-03-07 | 1984-08-24 | Interx Research Corp | Enhancement of absorption rate of orally administered antibiotics |
| JPS57146723A (en) * | 1981-03-06 | 1982-09-10 | Toyo Jozo Co Ltd | Pharmaceutical preparation having improved absorption |
| US4537772A (en) * | 1984-05-02 | 1985-08-27 | Merck & Co., Inc. | Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines |
| US5789234A (en) | 1987-08-14 | 1998-08-04 | Unigene Laboratories, Inc. | Expression systems for amidating enzyme |
| US5912014A (en) | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
| DK2088188T3 (da) | 1997-04-16 | 2012-01-02 | Unigene Lab Inc | Direkte ekspression af peptider i dyrkningsmedier |
| WO2001056594A1 (en) | 2000-02-04 | 2001-08-09 | Unigene Laboratories, Inc. | Nasal calcitonin formulations |
| US6673574B2 (en) | 2000-11-30 | 2004-01-06 | Unigene Laboratories Inc. | Oral delivery of peptides using enzyme-cleavable membrane translocators |
| US7316819B2 (en) | 2001-03-08 | 2008-01-08 | Unigene Laboratories, Inc. | Oral peptide pharmaceutical dosage form and method of production |
| CA2445860A1 (en) | 2001-04-30 | 2002-11-07 | Shire Laboratories Inc. | Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers |
| US8088734B2 (en) | 2003-01-21 | 2012-01-03 | Unigene Laboratories Inc. | Oral delivery of peptides |
| WO2005072277A2 (en) | 2004-01-21 | 2005-08-11 | Unigene Laboratories Inc. | Amidated parathyroid hormone fragments and uses thereof |
| US8227241B2 (en) | 2004-03-12 | 2012-07-24 | Unigene Laboratories, Inc. | Bacterial host cell for the direct expression of peptides |
| KR20050104152A (ko) | 2004-04-28 | 2005-11-02 | 최승호 | 경구용 약물의 흡수를 증진하는 약제학적 조성물 |
| US20050282756A1 (en) | 2004-06-18 | 2005-12-22 | Mehta Nozer M | Oral delivery of peptide pharmaceutical compositions |
| WO2006026592A2 (en) * | 2004-08-27 | 2006-03-09 | Spherics, Inc. | Oral administration of poorly absorbed drugs, methods and compositions related thereto |
| US7445911B2 (en) | 2004-11-24 | 2008-11-04 | Unigene Laboratories Inc. | Enzymatic reactions in the presence of keto acids |
| CN101287840B (zh) | 2005-06-24 | 2013-04-10 | 尤尼基因实验室公司 | 表达在酰胺化产物的制备中有用的酶的细胞系 |
| US7449896B2 (en) * | 2005-07-29 | 2008-11-11 | Ixys Corporation | Current sensor using level shift circuit |
| US8093207B2 (en) | 2005-12-09 | 2012-01-10 | Unigene Laboratories, Inc. | Fast-acting oral peptide pharmaceutical products |
| JP2009521456A (ja) * | 2005-12-22 | 2009-06-04 | ワイス | チゲサイクリンでの胃腸管感染症の治療法 |
| EP1964566A4 (en) * | 2005-12-22 | 2009-01-07 | Asubio Pharma Co Ltd | PREPARATION HAVING IMPROVED BIOABSORPTION CAPACITY OF SAPROPTERIN CHLORHYDRATE |
| AR060355A1 (es) * | 2007-04-04 | 2008-06-11 | Kelly Jose Luis | Aparato para disipar el agua producida por equipos de climatizacion |
| US8377863B2 (en) | 2007-05-29 | 2013-02-19 | Unigene Laboratories Inc. | Peptide pharmaceutical for oral delivery |
| US8609139B2 (en) * | 2007-11-05 | 2013-12-17 | Ala Wai Pharma, Inc. | Formulations for enhanced bioavailability of orally administered polar agents |
| US20100256060A1 (en) | 2009-04-02 | 2010-10-07 | Unigene Laboratories Inc. | Peptide pharmaceuticals for nasal delivery |
| US20120071410A1 (en) | 2010-09-21 | 2012-03-22 | Unigene Laboratories Inc. | Calcitonin products and therapies for treating inflammatory or degenerative diseases |
| RS60321B1 (sr) | 2010-12-16 | 2020-07-31 | Novo Nordisk As | Čvrste kompozicije koje sadrže glp-1 agonist i so n-(8-(2- hidroksibenzoil)amino)kaprilne kiseline |
| HK1197028A1 (en) | 2011-06-14 | 2015-01-02 | Stealth Peptides International, Inc. | Aromatic-cationic peptides and uses of same |
| CA2839298C (en) | 2011-06-15 | 2021-05-18 | Angelo P. Consalvo | Anti-inflammatory pharmaceutical products |
| CN105101950B (zh) | 2013-03-05 | 2019-10-11 | 安特里斯生物制药公司 | 口服递送的药物 |
| JP6910950B2 (ja) | 2015-01-12 | 2021-07-28 | エンテリス・バイオファーマ・インコーポレイテッドＥｎｔｅｒｉｓ Ｂｉｏｐｈａｒｍａ，Ｉｎｃ． | 固形経口剤形 |
-
2014
- 2014-03-05 CN CN201480020438.4A patent/CN105101950B/zh active Active
- 2014-03-05 US US14/197,405 patent/US9457086B2/en active Active
- 2014-03-05 DK DK14714013.1T patent/DK2964193T3/da active
- 2014-03-05 WO PCT/US2014/020763 patent/WO2014138241A1/en not_active Ceased
- 2014-03-05 CA CA2904327A patent/CA2904327C/en active Active
- 2014-03-05 EP EP14714013.1A patent/EP2964193B1/en active Active
- 2014-03-05 AU AU2014225822A patent/AU2014225822B2/en active Active
- 2014-03-05 ES ES14714013T patent/ES2774962T3/es active Active
- 2014-03-05 JP JP2015561608A patent/JP6375314B2/ja active Active
-
2015
- 2015-08-18 IL IL240666A patent/IL240666A0/en active IP Right Grant
-
2016
- 2016-06-16 US US15/184,971 patent/US9526785B2/en active Active
- 2016-11-16 US US15/353,213 patent/US9744140B2/en active Active
-
2017
- 2017-05-02 AU AU2017202900A patent/AU2017202900B2/en active Active
- 2017-07-21 US US15/656,142 patent/US20170319502A1/en not_active Abandoned
-
2018
- 2018-07-17 AU AU2018206721A patent/AU2018206721B2/en active Active